Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBIT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBIT Margin for 2 consecutive years, with 5773.71% as the latest value for Q1 2024.

  • For Q1 2024, EBIT Margin changed N/A year-over-year to 5773.71%; the TTM value through Dec 2024 reached 26806.37%, changed N/A, while the annual FY2024 figure was 26805.58%, 2678756.0% down from the prior year.
  • EBIT Margin hit 5773.71% in Q1 2024 for Artiva Biotherapeutics, down from 539.06% in the prior quarter.
  • Across five years, EBIT Margin topped out at 539.06% in Q4 2023 and bottomed at 5773.71% in Q1 2024.